Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-17

Clinical Trial Update: An Exploratory Study of Chenghuang Circadian Rhythm Regulator in Subjects With Sleep Disorders [NA]

View source ↗

Summary

An exploratory trial evaluating the Chenghuang Circadian Rhythm Regulator for sleep disorders has completed, according to the ClinicalTrials.gov record.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chenghuang Circadian Rhythm Regulator

Snippet

Sponsor: Shanghai Cell Therapy Group Co.,Ltd | Conditions: Sleep Disorders | NA | Status: COMPLETED